메뉴 건너뛰기




Volumn 14, Issue 4, 2013, Pages 315-321

Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: A randomized parallel-group study

Author keywords

albuminuria; Aliskiren; arterial hypertension; arterial stiffness; pulse wave velocity; valsartan

Indexed keywords

ALISKIREN; CLONIDINE; DILTIAZEM; DIURETIC AGENT; NEBIVOLOL; VALSARTAN;

EID: 84889804054     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312465219     Document Type: Article
Times cited : (9)

References (32)
  • 1
    • 12344282783 scopus 로고    scopus 로고
    • Global burden of hypertension: Analysis of worldwide data
    • DOI 10.1016/S0140-6736(05)17741-1, PII S0140673605177411
    • Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005 ; 365: 217-223 (Pubitemid 40138015)
    • (2005) Lancet , vol.365 , Issue.9455 , pp. 217-223
    • Kearney, P.M.1    Whelton, M.2    Reynolds, K.3    Muntner, P.4    Whelton, P.K.5    He, J.6
  • 3
    • 0030970060 scopus 로고    scopus 로고
    • Estimation of Central aortic pressure waveform by mathematical transformation of radial tonometry pressure: Validation of generalized transfer function
    • Chen CH, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997 ; 95: 1827-1836 (Pubitemid 27164400)
    • (1997) Circulation , vol.95 , Issue.7 , pp. 1827-1836
    • Chen, C.-H.1    Nevo, E.2    Fetics, B.3    Pak, P.H.4    Yin, F.C.P.5    Maughan, W.L.6    Kass, D.A.7
  • 4
    • 69549133604 scopus 로고    scopus 로고
    • Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?
    • Kalaitzidis RG, Bakris GL. Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?. Curr Opin Nephrol Hypertens. 2009 ; 18: 386-391
    • (2009) Curr Opin Nephrol Hypertens , vol.18 , pp. 386-391
    • Kalaitzidis, R.G.1    Bakris, G.L.2
  • 5
    • 34447521458 scopus 로고    scopus 로고
    • Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: A randomised, double-blind trial
    • DOI 10.1016/S0140-6736(07)61124-6, PII S0140673607611246
    • Oparil S, Yarows SA, Patel S, et al. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: A randomised, double-blind trial. Lancet. 2007 ; 370: 221-229 (Pubitemid 47069535)
    • (2007) Lancet , vol.370 , Issue.9583 , pp. 221-229
    • Oparil, S.1    Yarows, S.A.2    Patel, S.3    Fang, H.4    Zhang, J.5    Satlin, A.6
  • 7
    • 33644853054 scopus 로고    scopus 로고
    • Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study
    • Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation. 2006 ; 113: 657-663
    • (2006) Circulation , vol.113 , pp. 657-663
    • Mattace-Raso, F.U.1    Van Der Cammen, T.J.2    Hofman, A.3
  • 8
    • 33644863316 scopus 로고    scopus 로고
    • Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population
    • Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006 ; 113: 664-670
    • (2006) Circulation , vol.113 , pp. 664-670
    • Willum-Hansen, T.1    Staessen, J.A.2    Torp-Pedersen, C.3
  • 10
    • 0036150671 scopus 로고    scopus 로고
    • Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study
    • DOI 10.1161/hy0102.099031
    • Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension. 2002 ; 39: 10-15 (Pubitemid 34098081)
    • (2002) Hypertension , vol.39 , Issue.1 , pp. 10-15
    • Boutouyrie, P.1    Tropeano, A.I.2    Asmar, R.3    Gautier, I.4    Benetos, A.5    Lacolley, P.6    Laurent, S.7
  • 12
    • 0012666855 scopus 로고    scopus 로고
    • Aortic stiffness is an independent predictor of fatal stroke in essential hypertension
    • DOI 10.1161/01.STR.0000065428.03209.64
    • Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003 ; 34: 1203-1206 (Pubitemid 36547514)
    • (2003) Stroke , vol.34 , Issue.5 , pp. 1203-1206
    • Laurent, S.1    Katsahian, S.2    Fassot, C.3    Tropeano, A.-I.4    Gautier, I.5    Laloux, B.6    Boutouyrie, P.7
  • 13
    • 0037109215 scopus 로고    scopus 로고
    • Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function?
    • DOI 10.1161/01.CIR.0000033824.02722.F7
    • Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function?. Circulation. 2002 ; 106: 2085-2090 (Pubitemid 35192814)
    • (2002) Circulation , vol.106 , Issue.16 , pp. 2085-2090
    • Cruickshank, K.1    Riste, L.2    Anderson, S.G.3    Wright, J.S.4    Dunn, G.5    Gosling, R.G.6
  • 14
    • 75149139972 scopus 로고    scopus 로고
    • Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: A pilot study
    • Cherney DZ, Lai V, Scholey JW, et al. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: A pilot study. Diabetes Care. 2010 ; 33: 361-365
    • (2010) Diabetes Care , vol.33 , pp. 361-365
    • Cherney, D.Z.1    Lai, V.2    Scholey, J.W.3
  • 15
    • 33644851061 scopus 로고    scopus 로고
    • Arterial stiffness, vascular disease, and risk of cardiovascular events
    • Cohn JN. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation. 2006 ; 113: 601-603
    • (2006) Circulation , vol.113 , pp. 601-603
    • Cohn, J.N.1
  • 16
    • 0035569613 scopus 로고    scopus 로고
    • Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men
    • Kelly RP, Millasseau SC, Ritter JM, et al. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001 ; 37: 1429-1433 (Pubitemid 34225387)
    • (2001) Hypertension , vol.37 , Issue.6 , pp. 1429-1433
    • Kelly, R.P.1    Millasseau, S.C.2    Ritter, J.M.3    Chowienczyk, P.J.4
  • 18
    • 33645518432 scopus 로고    scopus 로고
    • Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study
    • Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006 ; 113: 1213-1225
    • (2006) Circulation , vol.113 , pp. 1213-1225
    • Williams, B.1    Lacy, P.S.2    Thom, S.M.3
  • 19
    • 84863588651 scopus 로고    scopus 로고
    • Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients
    • 2012
    • Virdis A, Ghiadoni L, Qasem AA, et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J. 2012 2012 ; 33: 1530-1538
    • (2012) Eur Heart J , vol.33 , pp. 1530-1538
    • Virdis, A.1    Ghiadoni, L.2    Qasem, A.A.3
  • 21
    • 45849123477 scopus 로고    scopus 로고
    • Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering
    • Karalliedde J, Smith A, DeAngelis L, et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension. 2008 ; 51: 1617-1623
    • (2008) Hypertension , vol.51 , pp. 1617-1623
    • Karalliedde, J.1    Smith, A.2    Deangelis, L.3
  • 22
    • 0028345245 scopus 로고
    • Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment
    • Rossing P, Hommel E, Smidt UM, et al. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia. 1994 ; 37: 511-516 (Pubitemid 24133655)
    • (1994) Diabetologia , vol.37 , Issue.5 , pp. 511-516
    • Rossing, P.1    Hommel, E.2    Smidt, U.M.3    Parving, H.-H.4
  • 23
    • 0037994715 scopus 로고
    • Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease
    • Apperloo AJ, de Zeeuw D, de Jong PE. Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int Suppl. 1994 ; 45: S174 - S178
    • (1994) Kidney Int Suppl , vol.45
    • Apperloo, A.J.1    De Zeeuw, D.2    De Jong, P.E.3
  • 26
    • 0029969837 scopus 로고    scopus 로고
    • The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
    • DOI 10.1016/S0149-2918(96)80040-3
    • Oparil S, Dyke S, Harris F, et al. The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension. Clin Ther. 1996 ; 18: 797-810 (Pubitemid 26397279)
    • (1996) Clinical Therapeutics , vol.18 , Issue.5 , pp. 797-810
    • Oparil, S.1    Dyke, S.2    Harris, F.3    Kief, J.4    James, D.5    Hester, A.6    Fitzsimmons, S.7
  • 27
    • 38049139424 scopus 로고    scopus 로고
    • Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease
    • Kunz R, Friedrich C, Wolbers M, et al. Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med. 2008 ; 148: 30-48 (Pubitemid 351688350)
    • (2008) Annals of Internal Medicine , vol.148 , Issue.1 , pp. 30-48
    • Kunz, R.1    Friedrich, C.2    Wolbers, M.3    Mann, J.F.E.4
  • 28
    • 0347479295 scopus 로고    scopus 로고
    • Blood Pressure Lowering in Essential Hypertension with an Oral Renin Inhibitor, Aliskiren
    • DOI 10.1161/01.HYP.0000101688.17370.87
    • Stanton A, Jensen C, Nussberger J, et al. Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension. 2003 ; 42: 1137-1143 (Pubitemid 37549068)
    • (2003) Hypertension , vol.42 , Issue.6 , pp. 1137-1143
    • Stanton, A.1    Jensen, C.2    Nussberger, J.3    Obrien, E.4
  • 29
    • 46449118638 scopus 로고    scopus 로고
    • Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats
    • Feldman DL, Jin L, Xuan H, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension. 2008 ; 52: 130-136
    • (2008) Hypertension , vol.52 , pp. 130-136
    • Feldman, D.L.1    Jin, L.2    Xuan, H.3
  • 32
    • 70349690296 scopus 로고    scopus 로고
    • Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria
    • Persson F, Rossing P, Reinhard H, et al. Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria. Diabetes Care. 2009 ; 32: 1873-1879
    • (2009) Diabetes Care , vol.32 , pp. 1873-1879
    • Persson, F.1    Rossing, P.2    Reinhard, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.